Literature DB >> 2228515

Intrapulmonary spread of established B16 melanoma lung metastases and lung colonies.

C W Stackpole1.   

Abstract

Spontaneous metastasis of subcutaneous B16 melanoma transplants proceeds in two distinct stages: initially to the lungs, and secondarily, following tumor removal, from established lung metastases to extrapulmonary systemic sites. Coincident with extrapulmonary metastasis, there is a dramatic amplification of visible lung metastases, with death generally resulting from extensive lung metastasis. The progression of lung metastasis, and lung colonization initiated by intravenous injection of tumor cells, was investigated using B16 melanoma clone G3.12. Analysis of the growth of invisible metastases in organ culture explants of lung revealed that tumors continually disseminated relatively small numbers of lung metastases after reaching a size of about 6 mm in diameter. However, most terminal-stage lung metastases, along with all extrapulmonary metastases, apparently arise from a secondary spread of tumor cells from tumor-derived lung metastases 1-2 mm in size. Individual lung colonies, initiated with G3.12 cells bound to single microbeads, also disseminated large numbers of secondary lung colonies, as well as extrapulmonary colonies, at a 1- to 2-mm size. The mechanism for intrapulmonary spread of secondary metastases and colonies is unclear, but the consequence appears to be a secondary stage of intrapulmonary and extrapulmonary metastasis with selection for tumor cells with rapid growth rates.

Entities:  

Mesh:

Year:  1990        PMID: 2228515

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  7 in total

1.  Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases.

Authors:  Yvonne Chao; Qian Wu; Marie Acquafondata; Rajiv Dhir; Alan Wells
Journal:  Cancer Microenviron       Date:  2011-09-03

2.  Patterning of B16 melanoma metastasis and colonization generally relates to tumor cell growth-stimulating or growth-inhibiting effects of organs and tissues.

Authors:  E F Valle; A D Zalka; L Groszek; C W Stackpole
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

3.  Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine.

Authors:  D Shrayer; H Bogaars; V J Hearing; A Maizel; H Wanebo
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

4.  [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression.

Authors:  J G Rajendran; D C Wilson; E U Conrad; L M Peterson; J D Bruckner; J S Rasey; L K Chin; P D Hofstrand; J R Grierson; J F Eary; K A Krohn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-11       Impact factor: 9.236

5.  Malignant progression of B16 melanoma cells induced in vitro by growth factors produced by highly malignant cells.

Authors:  C W Stackpole; L Groszek; S S Kalbag
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

6.  Activation of preexisting T cell clones by targeted interleukin 2 therapy.

Authors:  P T Straten; P Guldberg; T Seremet; R A Reisfeld; J Zeuthen; J C Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

7.  The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity.

Authors:  Duygu Sag; Caglar Cekic; Runpei Wu; Joel Linden; Catherine C Hedrick
Journal:  Nat Commun       Date:  2015-02-27       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.